Skip to Main Content
Luc “Luc P Brion” Brion, M.D.

Luc “Luc P Brion” Brion, M.D.

Professor Emeritus

School
Medical School
Department
Pediatrics

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    Download Curriculum Vitae

    Dr. Luc P Brion has published >130 manuscripts, 15 chapters, 20 clinical guidelines and presented >130 abstracts. During his training in pediatrics and in neonatology, he participated and conducted studies on growth, nutrition and assessment of renal function in neonates and children. As Faculty at the Albert Einstein College of Medicine in New York (AECOM), he was funded for years by the NIH, American Heart Association, Genentech Foundation, and Pharmacia for basic sciences research in developmental nephrology, specifically renal acid secretion, carbonic anhydrase, pathophysiological effects of acidosis and growth. Dr. Brion has served on the IRB at AECOM. Dr. Brion was Director of the Fellowship Training Program in Neonatal-Perinatal Medicine at AECOM in 1997-2006. He  was Director of the Fellowship Training Program in Neonatal-Perinatal Medicine at UTSW in 2007-2019.

    He has been research mentor for 40 trainees and >10 Faculty. He is a member of the Neonatal Review Group of the Cochrane Collaboration. He has participated in 5 randomized controlled trials (RCTs) in preterm infants and several multi-center research studies. From 2009 until 2023 he was the University of Texas Southwestern (UTSW) Alternate PI for the NICHD Eunice Kennedy Shriver Cooperative Multicenter Neonatal Research Network (NRN). Dr. Brion served on the subcommittee on protection of human subjects of the NRN. 

    Dr. Brion's current research interest includes (1) improving nutrition and growth in very preterm and very low birth weight infants to optimize neurodevelopment and to reduce signs suggestive of metabolic syndrome in high-risk preterm infants and (2) using evidence-based medicine to improve morbidity and morbidity (e.g., necrotizing enterocolitis) in neonates. 

    In preterm infants fed human milk, milk fortification can be adjusted by 1) optimization, based on growth rate and serum analyses, or 2) individualization, based on daily human milk nutrient analysis. Randomized allocation to adjusting macronutrients based on breast milk analysis in preterm neonates did not improve weight gain, linear growth or weight/length disproportion at 36 weeks postmentrual age or discharge. Follow-up at 18-38 months showed that the type of feeding supplementation had no effect on Bayley scores. At 3 years of age, infants in the experimental arm (individualized fortification) had central obesity and higher serum leptin:adiponectin ratio and central obesity compared with controls. Notably, serum leptin:adiponectin ratio was strongly correlated with weight gain and anthropometric measurements suggesting central obesity.  

    Valid serial length measurements in preterm infants were shown to permit characterization of growth patterns. A quality improvement project using adjustable feedings plus accurate serial length measurements was successful in reducing excessive weight gain and weight length disproportion at discharge without affecting linear growth, head growth or neurodevelopment. Among extremely low gestational age neonates (ELGANs) a serum Zinc concentration was obtained in 52 with insufficient linear growth (17%). Zinc supplementation for >2 weeks improved head growth to discharge or 50 weeks postmenstrual age in infants with Zinc deficiency. Additional studies are in process to assess linear growth, ventricular size and neurodevelopment. 

    A quality improvement project is in progress at Parkland Hospital, aiming at reducing necrotizing enterocolitis stage II or greater (Bell classification) among high-risk neonates, i.e., those born with gestational age < 33 weeks and those with birthweight < 1500 grams. Another project is designed to assess risk for either death or developing necrotizing enterocolitis stage III.

    In 2013 Dr. Brion took the Clinical Safety and Efficacy Course at UTSW. He supervised a team of research nurses who maintain the Divisional extensive neonatal intensive care unit (NICU) clinical databases at Parkland and Children’s Medical Center and databases for the Vermont Oxford Neonatal Network (VON) and Children’s Hospital Network Database (CHND). He compiled and presented an Annual Report of mortality and morbidity of neonates admitted to Parkland NICU and compared them to those of the NICHD NRN, VON and national data. He has used the databases for quality improvement and for research.

    Dr. Brion retired on April 10, 2023 and is now professor emeritus. 

     

  • Education
    Medical School
    Universite Libre de Bruxelles (1976)
    Residency
    Hopital Universitaire Saint-Pierre (1979), Pediatrics
    Residency
    Institut Edith Cavell (1981), Pediatrics
    Fellowship
    Hospital for Sick Children (1982), Neonatal-perinatal Medicine
    Fellowship
    Institut Edith Cavell (1982), Neonatal-perinatal Medicine
    Fellowship
    Cliniques Universitaires (1983), Neonatal-perinatal Medicine
    Fellowship
    Albert Einstein College of Medicine/Montefiore Medical Center (1985), Neonatal-perinatal Medicine
    Residency
    Montefiore Medical Center/ Albert Einstein College of Medicine (1986), Pediatrics
  • Research Interest
    • Necrotizing enterocolitis
    • Neonatal mortality/morbidity
    • Neonatal nutrition and gorwth
    • Renal disease
  • Publications

    Star Featured Publications

    A validated NICU database: recounting 50 years of clinical growth, quality improvement and research.
    Babata K, Rosenfeld CR, Jaleel M, Burchfield PJ, Oren MS, Albert R, Steven Brown L, Chalak L, Brion LP, Pediatr Res 2024 Oct
    Acetaminophen for Patent Ductus Arteriosus and Risk of Mortality and Pulmonary Morbidity.
    Jensen EA, DeMauro SB, Rysavy MA, Patel RM, Laughon MM, Eichenwald EC, Do BT, Das A, Wright CJ, Pediatrics 2024 Aug 154 2
    Multivariate Analysis of Factors Associated with Feeding Mother's Own Milk at Discharge in Preterm Infants: A Retrospective Cohort Study.
    Reis JD, Sánchez-Rosado M, Mathai D, Kiefaber I, Brown LS, Lair CS, Nelson DB, Burchfield P, Brion LP, Am J Perinatol 2024 Jul
    Maternal and neonatal outcomes associated with illness severity of maternal COVID-19.
    Sisman J, Adhikari EH, Black LF, Weiss A, Brown LS, Brion LP, J Neonatal Perinatal Med 2024 May
    Social Determinants of Health and Redirection of Care for Infants Born Extremely Preterm.
    Brumbaugh JE, Bann CM, Bell EF, Travers CP, Vohr BR, McGowan EC, Harmon HM, Carlo WA, Hintz SR, Duncan AF, JAMA Pediatr 2024 Mar
    Social distancing and extremely preterm births in the initial COVID-19 pandemic period.
    Shukla VV, Carper BA, Ambalavanan N, Rysavy MA, Bell EF, Das A, Patel RM, D'Angio CT, Watterberg KL, Cotten CM, Merhar SL, Wyckoff MH, Sánchez PJ, Kumbhat N, Carlo WA, J Perinatol 2024 Feb
    Association of maternal pre-pregnancy or first trimester body mass index with neurodevelopmental impairment or death in extremely low gestational age neonates.
    Chawla S, Laptook AR, Smith EA, Tan S, Natarajan G, Wyckoff MH, Greenberg RG, Ambalavanan N, Bell EF, Van Meurs KP, Hintz SR, Vohr BR, Werner EF, Das A, Shankaran S, J Perinatol 2024 Feb
    Neurodevelopmental Outcomes of Extremely Preterm Infants Fed Donor Milk or Preterm Infant Formula: A Randomized Clinical Trial.
    Colaizy TT, Poindexter BB, McDonald SA, Bell EF, Carlo WA, Carlson SJ, DeMauro SB, Kennedy KA, Nelin LD, Sánchez PJ, Vohr BR, Johnson KJ, Herron DE, Das A, Crawford MM, Walsh MC, Higgins RD, Stoll BJ, Ambalavanan N, Wyckoff MH, D'Angio CT, Bugg GW, Ohls RK, Reynolds AM, Sokol GM, Laptook AR, Olsen SL, White JR, Jadcherla SR, Bajaj M, Parimi PS, Schmidt B, Laughon MM, Barks J, Fisher KA, Hibbs AM, Peralta-Carcelen M, Cook N, Heyne RJ, Cavanaugh B, Adams-Chapman I, Fuller J, Hartley-McAndrew ME, Harmon HM, Duncan AF, Hines AC, Kilbride HW, Richards LA, Maitre NL, Natarajan G, Trembath AN, Carlson MD, Malcolm WF, Wilson-Costello DE, JAMA 2024 Feb 331 7 582-591
    Optimal Delivery Management for the Prevention of Early Neonatal SARS-CoV-2 Infection: Systematic review and Meta-analysis.
    Chan C, Kong JY, Sultana R, Mundra V, Babata K, Mazzarella K, Adhikari EH, Yeo KT, Hascoet JM, Brion L, Am J Perinatol 2024 Jan
    Development of a prediction model for surgery or early mortality at the time of initial assessment for necrotizing enterocolitis.
    Nayak SP, Sanchez-Rosado M, Reis JD, Brown LS, Mangona KL, Sharma P, Nelson DB, Wyckoff MH, Pandya S, Mir IN, Brion L, Am J Perinatol 2024 Jan
  • Books

    Featured 

    Clinical significance of developmental renal physiology. In RA Polin, WW Fox; Fetal and Neonatal Physiology

    Brion LP, Satlin LM (1998). Philadelphia, PA, Philadelphia, PA: Saunders.

    Kidney and Urinary Tract. In Fanaroff AA, Martin RJ, eds. Neonatal-Perinatal Medicine.

    Brion LP, Bernstein J, Spitzer A. (1997). St. Louis, MO: Mosby.

    Renal disease. In MacDonald MG, Mullett MD, Seshia MMK. Avery's Neonatology: Pathophysiology and Management of the Newborn.. 6th edition

    Nafday S, Brion LP, Benchimol C, Satlin LM, Flynn J, Edelmann CM Jr. (2005). Philadelphia, PA: JB Lippincott Company.

    Renal disease. In MacDonald MG, Mullett MD, Seshia MMK, eds. Avery's Neonatology: Pathophysiology and Management of the Newborn. 7th edition

    Nafday SM, Woda CB, Saland JM, Flynn JT, Askenzi D, Benchimol C, Brion LP. (2016). Philadelphia, PA: JB Lippincott Company.

    Neonatal Jaundice. In Campbell DE, ed. Neonatology for Primary Care.

    Kapadia VS, Brion LP. (2014). Elk Grove Village, IL: American Academy of Pediatrics.

    Neonatal jaundice in the term and near term infant. In TK McInerny, HM Adam, DE Campbell, DM Kamat, KJ Kelleher, eds. American Academy of Pediatrics Textbook of Pediatric Care.

    Brion LP. (2008). Elk Grove Village, IL: American Academy of Pediatrics.

    Renal Disease. In MacDonald MG, ed. Neonatology: Pathophysiology and Management of the Newborn.. 5th edition

    Brion LP, Satlin LM, Edelmann CM Jr. (1999). Philadelphia, PA: JB Lippincott Company.

    Neonatal jaundice.. In Campbell DE. Neonatology for Primary Care

    Johnson KA, Maple BB, Brion LP. (2020). Elk Grove Village, IL, American Academy of Pediatrics

    Renal disease.. In MacDonald MG, Mullett MD, Seshia MMK. Avery's Neonatology: Pathophysiology and Management of the Newborn.

    Nafday SM, Woda CB, Saland JM, Flynn JT, Askenazi D, Benchimol C, Brion (2021). Philadelphia., JB Lippincott Company,

    Neonatal jaundice. In McInerny T, Adam HM, Campbell DE, Foy JM, Kamat, DM, and DeWitt TG, eds. AAP Textbook of Pediatric Care

    Kapadia VS, Brion LP (2015). Elk Grove Village, IL, McInerny T, Adam HM, Campbell DE, Foy JM, Kamat, DM, and DeWitt TG. American Academy of Pediatrics.

    The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents.. In Pediatric Clinics of North America

    Schwartz GJ, Brion LP, Spitzer A. (1986). Phildelphia, PA, Elsevier

    Carbonic anhydrases in the nervous system. In WR Chegwidden, ND Carter, YH Edwards. The carbonic anhydrases: New Horizons.

    Cammer WB, Brion LP (2000). Basel, Switzerland, Birkhäuser Verlag

  • Honors & Awards
    • Top scholar - lifetime
      ScholarGPS (2024)
    • Provider of the Month, Children’s Medical Center of Dallas, NICU, May 2019
      (2019)
    • Elected to American Pediatric Society
      (2015)
    • ‘Individualizing and Optimizing Nutrition to Prevent Metabolic Syndrome and To Improve Neurodevelopment in Preterm and Small for Gestational Age Infants’
      Gerber Foundation, National Grant (2015-2019)
    • ‘Optimizing Individual Nutrition in Preterm Very Low Birth Weight Infants’
      Children’s Medical Center Clinical Advisory Committee (CCRAC) – Senior Investigator Research Award New Direction (2015-2017)
    • Site Alternate PI, UTSW, Dallas
      National Institute of Child Health and Human Development Eunice Kennedy Shriver Cooperative Multicenter Neonatal Research Network: (2011-2021)
    • Recognition by program directors for special contribution
      COGME, Albert Einstein College of Medicine, Bronx, NY (2006)
    • Listed in Top Doctors
      American Registry (2004-2005)
    • Best Doctors in America
      (2003-2014)
    • America's Registry of Outstanding Professionals
      (2002-2003)
    • Listed
      America’s Registry of Outstanding Professionals (2002-2003)
    • Listed in “Guide to America’s Pediatricians”
      Consumer’s Research Council of America (2002-2003)
    • Listed
      Strathmore’s Who’s Who (2001-2003)
    • New York Metro Area Top Doctors
      Castle Connolly Medical Ltd (2001-2005)
    • Listed in 3rd & 4th Eds, How to Find the Best Doctors: New York Metro Area
      Castle Connolly Guide (1998-1999)
    • Listed in ‘The Best Doctors in New York,’ Neonatal-Perinatal Medicine,
      New York Magazine (1998-2002)
    • Grant-in-Aid: ‘Regulation of renal membrane-bound carbonic anhydrase in response to acidosis’
      American Heart Association (1997-1999)
    • ‘Hormonal and cellular mechanisms of failure to thrive in acidotic mice’
      Pharmacia Inc (1997-1999)
    • Hormonal mechanisms of growth failure in chronic acidosis
      Pharmacia (1996-1997)
    • ‘Hormonal mechanisms of growth failure in chronic acidosis’
      Genentech Foundation for Growth and Development (1996-1998)
    • Interdivisional Research Award (IRA), ‘Role of somatotropin in growth retardation associated with chronic metabolic acidosis’
      Department of Pediatrics, Montefiore Medical Center (1995-1997)
    • “Molecular regulation of carbonic anhydrase IV isozymes’
      Department of Pediatrics Internal Grant, Montefiore Medical Center (1995-1997)
    • Biomedical Research Grants & Crisis Support Grant
      Albert Einstein College of Medicine (1990-1996)
    • Clinical Investigator Award: 'Regulation and development of renal acid-base transport'
      NIDDK (1990-1995)
    • Scholarship Award in Pediatrics
      Université Libre de Bruxelles, Brussels, Belgium (1976-1977)
    • Special Bachelor's Degree in Pediatrics
      Université Libre de Bruxelles, Brussels, Belgium (1976-1981)
    • Special Bachelor's Degree in Pediatrics
      Université Libre de Bruxelles, Brussels, Belgium (1976-1981)
    • Prix Fleurice Mercier
      Université Libre de Bruxelles (1970-1971)
  • Professional Associations/Affiliations
    • American Academy of Pediatrics (1987)
    • American Medical Association
    • American Pediatric Society (2014)
    • Cochrane Collaboration (1999)
    • Society of Pediatric Research (1992)